EGFR/HER2-IN-7 is a highly selective and potent anticancer compound designed to target MCF-7 breast cancer cells by functioning as a dual inhibitor of EGFR/HER2 kinases and DHFR (dihydrofolate reductase), with IC50 values of 0.18 µM for EGFR, 0.146 µM for HER2, and 0.907 µM for DHFR [1].
Molecular Weight:
355.45
Formula:
C19H21N3O2S
Target:
Others|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
